YOLFTbeta
Celltrion Pharm Inc

Celltrion Pharm Inc

068760 · KQ · Healthcare / Drug Manufacturers - Specialty & Generic

41,100.00KRW+850.00 (+2.11%)

Price History

Full chart

Market Stats

Previous Close40,250.00
Open41,100.00
Day Range40,850.00 – 42,500.00
52-Week Range37,000.00 – 78,300.00
Volume85.04K
Market Cap1.70T
P/E (TTM)0.00
Forward P/E49.51
Dividend Yield0.50%
Beta0.92
50-Day Avg40,922.00
200-Day Avg52,526.35

About

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea. Celltrion Pharm, Inc. (KOSDAQ:A068760) operates as a subsidiary of Celltrion, Inc.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Yoo Young-Ho
  • Employees0
  • Headquarters82, 2sandan-ro, Cheongju-si, South Korea, Korea
  • Websitehttps://www.celltrionph.com

Leadership

  • Sang-Suk KimPresident
  • Mr. Yoo Young-HoCEO & Executive Director

Financials

Income Statement

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue46.49B46.97B52.66B66.74B74.73B104.81B135.86B146.88B173.51B233.57B398.74B386.04B388.79B477.84B536.40B
Growth (%)-+1.02%+12.11%+26.75%+11.97%+40.25%+29.62%+8.11%+18.13%+34.61%+70.72%-3.18%+0.71%+22.90%+12.26%
Cost of Revenue13.89B14.33B16.39B22.69B26.84B52.64B77.57B106.29B111.05B160.40B279.48B273.27B269.08B355.82B372.62B
Gross Profit---43.17B47.89B52.17B58.29B40.59B62.47B73.16B119.25B112.77B119.71B122.01B163.78B
Gross Margin---64.67%64.08%49.78%42.90%27.63%36.00%31.32%29.91%29.21%30.79%25.53%30.53%
Operating Expense---34.82B41.52B44.90B49.62B40.92B48.04B49.53B71.46B74.60B86.31B84.79B107.69B
Operating Income6.11B5.08B7.49B8.35B6.37B7.27B8.67B-332.94M14.43B23.63B47.80B38.17B33.40B37.22B56.09B
Operating Margin13.15%10.81%14.23%12.51%8.53%6.94%6.38%-0.23%8.32%10.12%11.99%9.89%8.59%7.79%10.46%
EBITDA-----------54.10B54.22B57.36B78.63B
EBITDA Margin-----------14.02%13.95%12.00%14.66%
Net Income3.43B3.55B2.61B5.87B6.73B2.92B2.71B-9.39B8.60B20.94B34.58B25.96B21.26B21.97B38.75B
Net Income Margin7.39%7.56%4.96%8.79%9.01%2.78%2.00%-6.39%4.96%8.97%8.67%6.72%5.47%4.60%7.22%
R&D2.03B9.23B6.49B11.98B1.49B1.20B1.03B1.92B2.16B4.61B6.37B8.00B12.71B13.04B19.11B
R&D as % of Total Revenue4.36%19.66%12.32%17.94%1.99%1.15%0.76%1.31%1.24%1.97%1.60%2.07%3.27%2.73%3.56%
Interest Expense000000005.04B4.58B5.36B6.22B8.29B7.51B6.67B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%2.91%1.96%1.34%1.61%2.13%1.57%1.24%

Balance Sheet

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets216.08B331.04B361.35B411.16B466.77B510.02B470.27B452.44B470.98B548.07B637.88B599.72B641.64B669.46B759.44B
Total Liabilities87.81B173.80B192.94B196.74B230.54B165.37B176.65B182.41B190.95B247.51B305.92B242.94B264.98B272.54B323.48B
Total Equity128.27B157.25B168.41B214.43B236.23B344.65B293.62B270.03B280.03B300.56B331.97B356.79B376.67B396.92B435.96B
Cash3.69B5.49B11.62B3.56B9.70B10.19B5.64B9.12B10.76B25.75B80.19B31.39B19.71B45.48B49.87B
Total Debt-----138.73B137.37B133.23B147.77B178.85B-----
Net Debt---------166.27B99.91B128.85B138.44B109.40B92.13B

Cash Flow

Currency: KRW2006-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow----17.33B13.36B-15.21B-10.16B14.31B27.85B36.25B93.15B-4.05B8.76B56.59B86.43B
Investing Cash Flow-2.23B---44.57B-67.77B-8.63B-1.01B-7.33B-34.47B-44.88B-16.30B-14.57B-4.22B-12.12B-
Financing Cash Flow-3.10B74.12B105.73B19.16B60.53B24.32B6.65B-3.51B8.26B23.62B-22.41B-30.18B-16.21B-18.71B-
Capital Expenditure022.15B65.15B24.48B26.16B45.97B2.19B1.08B7.21B30.49B41.98B12.50B6.29B6.90B5.98B17.92B
Free Cash Flow-----------8.01B80.65B-10.33B1.86B50.61B68.51B
FCF to OCF-----------22.09%86.58%255.36%21.22%89.43%79.26%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Aug 13, 2015Nov 17, 2015Mar 18, 2016May 13, 2016Aug 12, 2016Nov 14, 2016Mar 7, 2017May 12, 2017Aug 11, 2017Nov 13, 2017Feb 28, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Feb 25, 2019Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Mar 18, 2021May 14, 2021Aug 17, 2021Nov 15, 2021Mar 8, 2022May 13, 2022Aug 16, 2022Nov 14, 2022Mar 20, 2023May 12, 2023Aug 13, 2023Nov 14, 2023Mar 18, 2024May 16, 2024Aug 14, 2024Sep 30, 2024Mar 17, 2025May 15, 2025Aug 12, 2025Sep 30, 2025Mar 16, 2026May 13, 2026Jun 30, 2026
EPS Estimate----------------------------------804.08791.38---------------------------------
EPS Actual-21.14118.31111.35-108.7039.4757.0066.1448.9216.7864.77-11.0746.8420.4479.8350.5354.244.0476.12-12.8320.7179.8943.0367.7736.7710.2232.05157.1961.094.4334.87-639.12-42.0227.1617.98-84.43-18.99-95.85-96.54-88.066.4144.9946.14100.7050.0587.3290.09289.02199.14361.07243.48111.76113.23200.36211.15156.83169.34267.5283.6517.1245.57134.94186.58149.92168.40255.36258.65204.43198.97309.98
Surprise-----------------------------------110.50%-102.40%---------------------------------
Timing------------------------After-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market-----------Pre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursPre-marketPre-market-Pre-marketPre-market-

Key Statistics & Ratios

Market Cap1.70T
Enterprise Value1.76T
Trailing P/E0.00
Forward P/E49.51
Price / Sales6.18
Price / Book3.85
Revenue (TTM)274.73B
Gross Profit (TTM)80.84B
EBITDA42.80B
Profit Margin9.47%
Operating Margin11.27%
Return on Equity8.91%
Return on Assets3.41%
Shares Outstanding44.26M
Shares Float19.72M
Beta0.92
Dividend Yield0.50%
Dividend Rate200.00
Payout Ratio20.58%

Dividends

20251×
200.00Dec 29, 2025
20061×
132.56Dec 27, 2006

Stock Splits

  • Dec 29, 202551:50
  • Dec 27, 202421:20
  • Dec 27, 202321:20
  • Dec 28, 202221:20
  • Dec 29, 2021103:100
  • Dec 29, 202051:50
  • Dec 27, 201921:20
  • Dec 27, 201751:50
  • Dec 28, 201621:20
  • Dec 29, 2015103:100
  • Dec 29, 201421:20